Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Premium

Register

Sign In

EUR/USD

1.2116

-0.0053

-0.44%

GBP/USD

1.3930

-0.0004

-0.03%

USD/JPY

109.34

-0.0730

-0.07%

USD/CHF

0.9879

0.0049

0.50%

EUR/GBP

0.8698

-0.0035

-0.41%

USD/CAD

1.2871

0.0032

0.25%

NZD/USD

0.7064

-0.0004

-0.05%

EUR/JPY

132.48

-0.6715

-0.50%

EUR/CHF

1.1969

0.0007

0.06%

Acasti Pharma Inc.

NASDAQ: ACSTHealthcare / Biotechnology / Canada
0.7800.00Vol 37 3971Y Perf -39.23%
Apr 26th, 2018 10:50
BID0.77 ASK0.78
Open0.78 Previous Close0.78
Pre-Market- After-Trading-
 - -%  - -%
Target Price
4.70 
Analyst Rating
Strong Buy 1.00
Potencial %
510.39 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
★+     38.98
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)20 
Earnings Rating
Price Range Ratio 52wk %
1.15 
Earnings Date

Today's Price Range

0.770.78

 

52wk Range

0.753.36

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
-22.77%
3 Months
-31.58%
6 Months
-39.53%
1 Year
-39.23%
3 Years
-82.67%
5 Years
-96.69%
Last Quotes
Name / TickerPriceChg.Chg.%
ACST0.780.00000.00
AAPL165.391.74001.06
GOOG1 037.0015.82001.55
MSFT94.301.99002.16
XOM80.080.58000.73
WFC52.98-0.1300-0.24
JNJ127.630.87000.69
FB173.1513.46008.43
GE14.290.24001.71
JPM110.170.18000.16
...

TickerPriceChg.%52 Week High
CMG416.8622.78499.00
ORLY261.2414.75279.23
AMD11.0213.4915.65
ALXN116.8110.16149.34
FB173.158.43195.32
AZO649.756.42797.89
AAP114.706.38151.72
TSCO65.885.9382.68
CTXS101.535.13102.88
KIM13.904.9821.85
INTU184.464.59184.50
ABBV95.984.47125.86
BAX69.304.1872.58
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 2.60
Current Ratio 2.70
Long Term Debt to Total Capital 0.09
Total Debt to Equity 0.10
Interest Coverage -81.10
Leverage Ratio 1.40
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-162.30
EBIT Margin-34 664.40
EBITDA Margin-25 968.80
Pre-tax Profit Margin-7 486.20
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 2.20
PS Ratios 22 959.00
Price to Cash Flow -
Price to Free Cash Flow -4.00
Cash Flow Per Share -0.25
Price to Tangible Book7.31
Book Value per Share0.47
Enterprise Value (in ths.)14 473
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-32.28
ROE last 12 Months -94.92
Return on Assets (5Y Avg) -31.34
ROA last 12 Months -68.29
Return on Capital (5Y Avg) -31.80
ROC last 12 Months -40.74
Return on invested Capital Q -36.22
Return on invested Capital Y-21.14
Assets Turnover0.00
Receivables Turnover0.00
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)1
Revenue per Share 0.00
Revenue Growth 3 Years -77.66
Revenue Growth 5 Years -64.51
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q04 2017-0.31-0.310.00
Q01 2017--0.23-
Q04 2016--0.13-
Q03 2016--0.16-
Q02 2016--0.01-
Q01 2016--0.01-
Q04 2015--0.02-
Q03 2015-0.030.03200.00
Earnings Per EndEstimateRevision %Trend
3/2018 QR-0.20--
3/2018 QR-0.20--
----
----
Next Report Date10th Oct 2017
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume37 397
Shares Outstanding (in ths.)25 600
Trades Count21
Dollar Volume18 208
Avg. Volume321 332
Avg. Weekly Volume421 893
Avg. Monthly Volume277 908
Avg. Quarterly Volume222 546

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

86%14%

Bearish Bullish

80%20%

Bearish Bullish

50%50%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
0
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0
Hold
0 (0.00 %)
0 (0.00 %)
0
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0
Strong Sell
0 (0.00 %)
0 (0.00 %)
0
RatingStrong Buy
1.00
Strong Buy
1.00
-

There are no comments yet.

News

x